Monday, September 10 |
||
Time |
Activity |
Speaker |
8:30 |
CLOSED SESSION called to order |
Ned Calonge, Chair |
8:30 –8:45 |
Welcome and Opening Statement |
Ned Calonge |
8:45– 9:00 |
Status updates and review of briefing book materials |
Dave Dotson |
9:00 - 9:15 |
CDC updates |
Muin Khoury |
9:15 - 10:15 | Whole Genome Sequencing discussion | Katrina Goddard & Ned Calonge |
10:15 - 10:30 |
Break |
|
10:30 - 12:00 |
Familial Hypercholesterolemia |
Katrina Goddard |
12:00 - 1:00 |
Lunch |
|
1:00 - 2:00 |
CYP2C19 Testing/Anti-platelet therapy (Clopidigrel) – review & recommendation |
EPC Representative & Michael Douglas |
2:00 - 3:30 | CRC collaboration planning discussion | Muin Khoury & Ned Calonge |
3:30 - 3:45 |
Break | |
3:45 - 5:00 |
CRC collaboration planning (continued) |
Dave Dotson |
5:00 - 5:15 |
Wrap-up and Adjourn Closed Session | Ned Calonge |
Tuesday, September 11 |
||
Time |
Activity |
Speaker |
9:00 | Open Session called to order | Ned Calonge |
9:00 – 9:15 |
Overview of Day 1, brief staff updates and outstanding questions |
Ned Calonge & Staff |
9:15 – 9:45 |
CYP450 Update Report |
Dave Dotson |
9:45 – 10:15 | Prostate Cancer SNP Panel Recommendation | Dave Dotson |
10:15 – 10:45 |
Break |
|
10:45 – 11:45 |
Prostate Cancer / PCA3 - review & recommendation |
Glenn Palomaki & Michael Douglas |
11:45 – 12:00 | Public Comment | |
12:00 – 1:00 |
Wrap Up and Action Items |
Ned Calonge & Staff |
1:00 |
Adjourn CLOSED SESSION |
Ned Calonge |
Historical Document
Page last updated: September 12, 2013
Page last reviewed: September 12, 2013
Content Source: OPHG Staff